Monoclonal antibody therapy improves severity and mortality of COVID-19 in organ transplant recipients: A meta-analysis.

• Included studies compared the effect of monoclonal antibody therapy on clinical outcomes of organ transplant recipients with COVID-19. • A total of 8 articles comprising 930 organ transplant recipients with COVID-19 were included in the analysis. • Monoclonal antibody therapy significantly improve both severity and mortality among organ transplant recipients with COVID-19. [ABSTRACT FROM AUTHOR]